Clinical Trial Update: Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing varenicline for smoking cessation after acute coronary syndrome completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Smoking Cessation

Drugs mentioned

• Champix (varenicline)

Snippet

Sponsor: Mark Eisenberg | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2019-05-23